Classification
Product TypeProcessed Food
Product FormDose form (prepacked tablets/capsules)
Industry PositionConsumer Packaged Food Supplement
Market
Vitamin B-complex supplements in Germany are marketed as food supplements (foods) in dose form such as tablets and capsules, and are widely sold through mainstream retail channels. Germany requires manufacturers/importers to notify food supplements to the BVL at (or before) first placing on the market, and there is no pre-market authorisation like for medicines. Product labelling and advertising are tightly constrained: mandatory supplement statements apply, and health claims must follow EU nutrition and health-claims rules. A key formulation constraint for B-complex products is vitamin B6: EFSA set an adult UL of 12 mg/day, and BfR issued a 2024 recommendation of a maximum 0.9 mg vitamin B6 per daily portion from a supplement product for people aged 15+.
Market RoleMature domestic consumer market with active brand competition under EU/German food-supplement rules
Domestic RoleMainly consumer wellness product sold through pharmacies, drugstores, food retail and online
SeasonalityYear-round availability (manufactured shelf-stable product); no agricultural seasonality.
Specification
Physical Attributes- Dose form in small, measured units (e.g., tablets/capsules) for daily consumption
- Common pack formats include blisters or bottles with labelled daily portion guidance
Compositional Metrics- Declared vitamin content per daily portion (e.g., mg/µg and %NRV)
- Vitamin B6 level should be checked against EFSA UL context and German risk-management recommendations (BfR proposals) to avoid excessive-dose products
Packaging- Blister packs (tablets/dragees) in cartons
- HDPE/PET bottles or jars with desiccant for tablets/capsules
- Tamper-evidence and clear German-language labelling
Supply Chain
Value Chain- Vitamin premix sourcing -> incoming QC (identity/potency/contaminants) -> blending -> tableting or encapsulation -> optional coating / sustained-release matrix -> packaging & labelling (German/EU compliant) -> distribution (pharmacies/drugstores/food retail/online)
Temperature- Typically ambient distribution; protect from heat, moisture and light to reduce potency loss risk
Shelf Life- Shelf life is driven by vitamin stability and packaging barrier performance; potency monitoring over shelf life is a key quality-control focus
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighHigh-dose B-complex formulations (especially vitamin B6) can trigger marketability challenges in Germany: BfR’s 2024 risk-management proposal recommends a maximum of 0.9 mg vitamin B6 per daily portion from a supplement product for people aged 15+, and products positioned with medicinal effects or pharmacological intent may be treated as medicinal products requiring authorisation rather than as food supplements.Set formulation and daily portion with EFSA UL context and BfR proposals in mind, and run a Germany-specific compliance review on product positioning/claims to avoid medicinal-product classification.
Food Safety MediumAdulteration or presence of unauthorised substances in supplements is a recurring EU enforcement issue and can lead to rapid withdrawal/recall actions communicated through EU alert systems.Implement strong supplier qualification, identity testing and contaminant/adulterant screening with batch release controls and retention samples.
Labeling MediumMissing or incorrect mandatory German-language supplement statements (e.g., daily portion, warning not to exceed, and ‘not a substitute for a varied diet’) and non-compliant health-claim wording can lead to non-compliance findings by authorities and delisting by retailers.Validate labels against NemV and EU FIC/claims rules; use only permitted health claims and the required accompanying conditions.
FAQ
Do vitamin B-complex supplements need pre-market approval in Germany?No. In Germany, food supplements do not go through a pre-market authorisation like medicines. The manufacturer or importer must notify the product to the BVL when placing it on the market, but that notification is not an approval.
Is notification to the BVL required when selling a B-complex supplement in Germany?Yes. Under NemV §5, anyone intending to place a food supplement on the German market as a manufacturer or importer must notify it to the BVL and submit a sample of the label used for the product.
Why is vitamin B6 dose a key compliance risk for B-complex supplements in Germany?EFSA set an adult tolerable upper intake level (UL) of 12 mg/day for vitamin B6 based on peripheral neuropathy risk, and BfR’s 2024 opinion recommends a maximum of 0.9 mg vitamin B6 per daily portion from a supplement product for people aged 15+. High-dose products can therefore face elevated compliance and enforcement risk.
What are core mandatory label statements for food supplements in Germany?Germany’s NemV requires the product to be labelled as a food supplement and to include items such as the recommended daily portion, a warning not to exceed the stated daily dose, and statements that supplements are not a substitute for a varied diet and should be kept out of reach of young children.